ERYP - ERYTECH receives non-compliance letter from Nasdaq
- Erytech Pharma ( NASDAQ: ERYP ) said it had received a notification from Nasdaq indicating that it was no longer in compliance with the listing rules based on closing bid price of less than $1 per share for tits American Depositary Shares for the prior 30 consecutive business days.
- The Notification Letter has no immediate effect on the listing of the ADSs, the company said.
- The company has 180 days, or until April 5 to regain compliance.
- The Company can cure this deficiency if the closing bid price of its ADSs is $1.00 per share or higher for at least ten consecutive business days.
For further details see:
ERYTECH receives non-compliance letter from Nasdaq